Compounds > 5- ethylamino-9-diethylaminobenzo(a)phenoselenazinium
Page last updated: 2024-12-11

5- ethylamino-9-diethylaminobenzo(a)phenoselenazinium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5- ethylamino-9-diethylaminobenzo(a)phenoselenazinium: structure in first source; RN refers to the chloride salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6336144
MeSH IDM0216849

Synonyms (6)

Synonym
5-ethylamino-9-diethylamino-benzo(a)phenoselenazinium chloride
136825-97-3
5-ethylamino-9-diethylaminobenzo(a)phenoselenazinium
benzo(a)phenoselenazin-7-ium, 9-(diethylamino)-5-(ethylamino)-, chloride
5- ethylamino-9-diethylaminobenzo(a)phenoselenazinium
etnbse
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.75 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
nile blue
Nile Blue: RN given refers to chloride; structure. nile blue A : An organic chloride salt having 5-amino-9-(diethylamino)benzo[a]phenoxazin-7-ium as the couterion. fluorescent dye which is also a potent photosensitiser for photodynamic therapy.		1.9910
5-ethylamino-9-diethylaminobenzo(a)phenothiazinium
5-ethylamino-9-diethylaminobenzo(a)phenothiazinium: structure in first source; RN refers to the chloride salt		2.6930
ConditionIndicatedRelationship StrengthStudiesTrials
Leishmaniasis, American
[description not available]		02.0310
Leishmaniasis, Cutaneous
An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.		02.0310
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		02.0310
Granulomas
[description not available]		02.0310
Koch's Disease
[description not available]		02.0310
Granuloma
A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.		02.0310
Tuberculosis
Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.		02.0310
Sarcoma, Epithelioid
[description not available]		01.9810
Animal Mammary Carcinoma
[description not available]		01.9810
Sarcoma
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.		01.9810